Related Experiment Video

Updated: Mar 1, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.3K

Targeting Melanoma with Cancer-Killing Viruses

Tiantian Zhang1, Yogesh R Suryawanshi1, Helene M Woyczesczyk1

  • 1Laboratory of Virology, Department of Biological Sciences, Western Michigan University, Kalamazoo, MI, 49008, U.S.A.

The Open Virology Journal
|June 2, 2017
PubMed

Insights

Oncolytic viruses (OVs) show promise in treating melanoma by directly killing cancer cells and stimulating the immune system. Research is exploring how to engineer OVs to better target melanoma's specific abnormalities.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Melanoma incidence is rising, and metastatic disease remains difficult to treat.
  • Oncolytic viruses (OVs) offer a dual mechanism for tumor reduction: direct cell lysis and immune response induction.
  • OVs have demonstrated efficacy in experimental and clinical melanoma studies.

Purpose of the Study:

  • To review the mechanisms of action for oncolytic viruses in melanoma treatment.
  • To summarize melanoma biomarkers and deregulated pathways relevant to therapy.
  • To explore potential for engineering enhanced oncolytic viruses for melanoma.

Main Methods:

  • Comprehensive literature review of oncolytic virus mechanisms in melanoma.
  • Analysis of molecular and cellular targets within melanoma.
  • Examination of melanoma biomarkers and signaling pathways.

Main Results:

  • OVs target melanoma by enhancing viral tropism, modifying the tumor microenvironment, and boosting anti-tumor immunity.
  • Melanoma's specific abnormalities, including biomarkers and deregulated pathways, are key targets.
  • Understanding these abnormalities aids in developing targeted and immuno-therapies.

Conclusions:

  • Oncolytic viruses are a promising therapeutic strategy for melanoma.
  • Engineering OVs based on melanoma-specific vulnerabilities could improve efficacy.
  • Advances in understanding melanoma biology are crucial for future OV development.
Keywords:
BiomarkersCombinational therapyImmune enhancementImmunotherapyMelanomaOncolytic virotherapyTumor microenvironmentTumor targeting

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

4.1K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

1.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K